Recruiting Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging NCT07613099 Conditions Acute Lung Injury, Allogeneic Stem Cell Transplantation, Cardiovascular Diseases, +8 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
